The largest database of trusted experimental protocols

Ni nta bead

Manufactured by Qiagen
Sourced in Germany, United States, Netherlands, France

Ni-NTA beads are a type of agarose-based affinity resin used for the purification of recombinant proteins that contain a polyhistidine (His) tag. The Ni-NTA (Nickel-Nitrilotriacetic Acid) moiety on the beads binds to the His-tagged proteins, allowing them to be separated from other cellular components during the purification process.

Automatically generated - may contain errors

302 protocols using ni nta bead

1

Purification of Recombinant TrmO and TRMO Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
An E. coli strain carrying plasmid pCA24N, for expression of soluble recombinant TrmO protein fused to a N-terminal 6×His tag, was obtained from the ASKA clone collection [NBRP (NIG, Japan): E. coli] (57 (link)). This strain was cultivated in the presence of 0.1 mM IPTG to induce protein expression, and the expressed protein was purified using Ni-NTA beads (QIAGEN) packed in an open column. The pooled protein was dialyzed against a buffer consisting of 50 mM Tris–HCl (pH 7.5), 1 mM DTT, and 100 mM KCl.
The cDNA encoding the human homolog TRMO, obtained by nested RT-PCR using specific primers (Supplementary Table S2) from total RNA of HeLa cells, was cloned into the NheI and SalI sites of vector pET28a to yield pET28a-TRMO (Novagen). BL21 (DE3) Rosetta was transformed with pET28a-TRMO, and the transformant strain was cultured at 37°C. When OD600 reached 0.7, expression of the recombinant protein was induced with 0.1 mM IPTG at 18°C for 3 h. The harvested cells were lysed by sonication in a buffer containing 25 mM Tris-HCl (pH 8.0), 300 mM NaCl, 10% glycerol, and 0.2 mM phenylmethylsulfonyl fluoride (PMSF). Recombinant TRMO was purified with Ni-NTA beads (QIAGEN). TRMO was eluted with 250 mM imidazole, and then passed through a PD-10 column (GE Healthcare) in cell lysis buffer containing 1 mM DTT.
+ Open protocol
+ Expand
2

Purification of His10-SUMO2 and His10-Ubiquitin Conjugates

Check if the same lab product or an alternative is used in the 5 most similar protocols
Proteins conjugated to His10-SUMO2 or His10-ubiquitin were purified as described previously [31 (link)]. U2OS and Namalwa cells stably expressing His10-SUMO2 or His10-ubiquitin were lysed in 6 M Guanidine-HCL, 100 mM Sodium phosphate, 10 mM Tris, buffered at a pH of 7.8 and subsequently snap frozen. Lysates were thawed at room temperature, sonicated 2x for 10 s, supplemented with 5 mM β-mercaptoethanol and 50 mM imidazole pH 8.0. Samples were equalized using the bicinchoninic acid (BCA) Protein Assay (Merck). Ni-NTA beads (30210, Qiagen, Hilden, Germany) were added to the lysates and incubated overnight at 4 ˚C. Ni-NTA beads were washed extensively. Purified proteins were eluted three times in one bead volume of 7 M urea, 100 mM sodium phosphate, 10 mM Tris pH 7.0, and 500 mM imidazole pH 7.0. Elutions obtained for immunoblot analysis were supplemented with LDS sample buffer. Elutions for mass spectrometry analysis were trypsin digested.
+ Open protocol
+ Expand
3

Ubiquitination Analysis Using Flag-Conjugated or Ni-NTA Beads

Check if the same lab product or an alternative is used in the 5 most similar protocols
For ubiquitination using Flag-conjugated agarose beads or Flag primary antibody plus protein A/G beads, 293T cells were transfected with plasmids for HA-Ub, Flag-53BP1, and other indicated constructs. Cells were harvested and lysed with lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% NP40, 0.5% sodium deoxycholate, and 1× protease inhibitor cocktail (PIC)). The lysate was subjected to co-IP using anti-Flag-conjugated agarose beads or Flag primary antibody plus protein A/G beads.
For ubiquitination using nickel-nitrilotriacetic acid (Ni-NTA) beads (QIAGEN), cells were transfected with His-ubiquitin and indicated constructs for 42 h. Subsequently, cells were lysed with buffer A (6 M guanidine-HCl, 0.1 M Na2HPO4/NaH2PO4, and 10 mM imidazole [pH 8.0]) and sonicated for 15 s. After incubating with nickel-nitrilotriacetic acid (Ni-NTA) beads (QIAGEN) for 3 h at room temperature, the proteins were washed twice with buffer A, twice with buffer A/TI (1 volume buffer A and 3 volumes buffer TI), and one time with buffer TI (25 mM Tris-HCl and 20 mM imidazole [pH 6.8]). The pull-down proteins were denatured at 95 °C for 5 min and separated by SDS-PAGE for immunoblotting.
+ Open protocol
+ Expand
4

Purification of His-tagged Proteins from Yeast

Check if the same lab product or an alternative is used in the 5 most similar protocols
Yeast cultures (200 ml) were grown to mid-log phase on YPD at 30°C and were subsequently harvested via centrifugation. A suspension consisting of equal volumes of cell pellet, glass beads and lysis buffer (20 mM HEPES-KOH pH 8.0, 120 mM potassium acetate, 2 mM magnesium acetate, 30 mM imidazole, 1 mM EDTA, 1 mM PMSF, protease inhibitor mix, 1× phosSTOP (Roche)) was prepared and glass bead disruption was performed by four cycles of vortexing for 30 s followed by 30 s incubation on ice and the resulting lysate was then cleared by centrifugation at 20000 × g for 10 min. For each pull-down reaction, 20 μl of Ni-NTA beads (Quiagen, Superflow) were pre-coated with 300 μg/ml trypsin inhibitor for 60 min to block unspecific binding. Cleared lysate and lysis buffer were mixed to a final protein concentration of ∼30 mg/ml and 1 ml of the mixture was added to the pre-coated Ni-NTA beads. Pull-down reactions were incubated at 4°C for 45 min with gentle agitation, Ni-NTA beads were then collected and were washed twice with 0.5 ml washing buffer (20 mM HEPES-KOH pH 8.0, 250 mM potassium acetate, 2 mM magnesium acetate, 100 mM imidazole, 1 mM PMSF, protease inhibitor mix). Bound proteins were released by boiling Ni-NTA beads at 95°C in sample buffer. Analysis was performed on 10% Tris-Tricine gels (36 (link)) followed by immunoblotting.
+ Open protocol
+ Expand
5

Expression and Purification of Recombinant Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
All recombinant proteins were expressed in Escherichia coli BL21(DE3) CodonPlus cells (Stratagene) in LB (for crystallographic studies) or M9 minimal medium (for NMR studies) containing 13C-glucose and/or 15NH4Cl as sole sources of carbon and nitrogen, respectively. All recombinant proteins used for structural and biophysical characterization were lysed by sonification in lysis buffer (50 mM sodium phosphate (pH 7.5), 300 mM NaCl, 10 mM imidazole, and 1 mM DTT). Cell debris was removed by centrifugation and the filtered supernatant applied to Ni-NTA beads (Quiagen) for affinity chromatography. Purified proteins were eluted with lysis buffer containing 300 mM imidazole. The elution fractions were supplemented with His-tagged TEV protease (except for the RPN10 UIM2) and dialyzed in dialysis buffer (50 mM sodium phosphate (pH 7.5), 300 mM NaCl, and 1 mM DTT). After cleavage, the desired proteins were separated from His6-tagged cleavage products and His6-tagged TEV protease by Ni-affinity chromatography using dialysis buffer. All proteins were further purified by size-exclusion gel filtration. Pure proteins for NMR and DSF analyses were buffer exchanged to NMR buffer (20 mM sodium phosphate pH 7.5, 150 mM NaCl) that contained 1 mM DTT for proteins containing Cys residues. For crystallization, proteins were in 20 mM HEPES (pH 7.5), 150 mM NaCl.
+ Open protocol
+ Expand
6

Proteomic Analysis of Ubiquitylation and SUMOylation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ubiquitylation and SUMOylation were performed as previously described (Abed et al., 2011 (link); Trausch-Azar et al., 2015 (link)). Where indicated, cells were incubated with 40 µM MG132 for 4 hr and subjected to hot lysis, followed by immune precipitation. Where His-Ub was used, cells were lysed in 1 ml guanidine-hydrochloride buffer, followed by binding to Ni-NTA beads (QIAGEN) in the presence of 20 mM imidazole. Ubiquitylated and SUMOylated proteins were visualized via SDS-PAGE gels followed by western blotting.
+ Open protocol
+ Expand
7

Recombinant Histone Production and Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
All histones were bacterially expressed as His6-tagged recombinant proteins12 (link),58 (link)–60 (link). Human histones H2A, H2B, H3.1, H3.1CATD, and H3.1CATD(V76Q, K77D) were produced in E. coli BL21(DE3). CENP-A, CENP-AQD was produced in E. coli BL21-CodonPlus(DE3)-RIL. Human histone H4 was produced in E. coli JM109(DE3). The Se-Met-substituted H2A L51M, L58M, L93M and Se-Met-substituted H2B were produced in E. coli B834(DE3). Expressed histones were corrected from the inclusion body and purified by Ni affinity chromatography using Ni-NTA beads (QIAGEN) under denaturing condition. His6-tags of these purified histones were removed by treatment with thrombin protease (Wako or GE Healthcare) under non-denaturing condition. After thrombin protease treatment, histones were further purified by ion exchange chromatography using MonoS column (GE Healthcare) under denaturing condition. Purified histones were dialyzed against water containing 2 mM 2-mercaptoethanol and lyophilized. Lyophilized histone powders were stored at 4 °C.
+ Open protocol
+ Expand
8

Purification of T7 Lysozyme Fusion Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
T7 lysozyme was expressed as C-terminally His-tagged fusion protein in BL21 DE3 RIL cells; 1 L of cells was grown to log phase, induced with 1 mM IPTG at 37°C for 3 hr. Cells were harvested by centrifugation for 30 min at 4000 rpm and resuspended in buffer L (50 mM Tris-HCl pH 7.6/10% glycerol/0.02% NP-40)/300 mM NaCl/protease inhibitor cocktail/1 mM DTT. Cells were lysed by incubation with 0.1 mg/mL lysozyme for 30 min on ice followed by sonication. Cleared lysate was obtained by centrifugation at 15,000 rpm in an SS34 rotor for 30 min at 4°C. The clarified extract was supplemented with 10 mM imidazole and rotated for 2 hr at 4°C with 1 mL of Ni-NTA beads (Qiagen). Bound protein was eluted with 10 CV of buffer L/200 mM imidazole. Peak fractions were pooled, diluted with buffer L to lower the salt concentration to 10 mM NaCl, and fractionated over a 1 mL MonoS column using a 20 CV gradient of 10–125 mM NaCl in buffer L. Peak fractions were pooled, concentrated using Amicon Ultra 4 mL centrifugal filters (Millipore) and fractionated over 24 mL S200 gel filtration column equilibrated in buffer L/125 mM NaCl. Peak fractions were pooled, aliquoted, flash-frozen, and stored at –80°C.
+ Open protocol
+ Expand
9

Recombinant Protein Purification and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
The recombinant proteins were expressed in Lenti-X 293T cells by calcium phosphate transfection and purified by affinity chromatography with protein A (GE Healthcare) and Ni-NTA beads (Qiagen). Gel filtration of the proteins were performed on an ÄKTA purifier system with Unicorn 5.1 software (GE Healthcare) using PBS as running buffer at a constant flow rate of 0.1 ml/min. 200 μg protein was loaded on a Superdex 200 10/300 GL column (GE Healthcare). Ovalbumin and aldolase of the Gel Filtration HMW Calibration Kit (GE Healthcare) were used as molecular weight controls. Quantifications were done by capillary electrophoresis (Experion Pro260 kit; Bio-Rad). Purity and molecular masses of TP15-Fc and 4D5-Fc (5 μg protein each) were analyzed on Coomassie gel by using standard procedures.
+ Open protocol
+ Expand
10

Recombinant Human Pin1 Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
A construct of full-length human Pin1 in a pET28 vector was overexpressed in E. coli BL21 (DE3) in LB medium in the presence of 50 mg/ml of kanamycin. Cells were grown at 37°C to an OD of 0.8, cooled to 17°C, induced with 500 μM isopropyl-1-thio-D-galactopyranoside, incubated overnight at 17°C, collected by centrifugation, and stored at −80°C. Cell pellets were sonicated in buffer A (50 mM HEPES pH 7.5, 300 mM NaCl, 10% glycerol, 10 mM Imidazole, and 3 mM BME) and the resulting lysate was centrifuged at 30,000 ×g for 40 min. Ni-NTA beads (Qiagen) were mixed with lysate supernatant for 30 min and washed with buffer A. Beads were transferred to an FPLC-compatible column and the bound protein was washed with 15% buffer B (50 mM HEPES pH 7.5, 300 mM NaCl, 10% glycerol, 300 mM Imidazole, and 3 mM BME) and eluted with 100% buffer B. Thrombin was added to the eluted protein and incubated at 4°C overnight. The sample was concentrated and passed through a Superdex 200 10/300 column (GE helathcare) in a buffer containing 20 mM HEPES, pH 7.5, 150 mM NaCl, 5% glycerol, 3 mM DTT, and 1 mM TCEP. Fractions were pooled, concentrated to approximately 37 mg/ml and frozen at −80°C.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!